Lataa...
Differential Use of Warfarin for Secondary Stroke Prevention in Patients With Various Types of Atrial Fibrillation
Anticoagulation therapy significantly reduces the incidence of thromboembolic events in patients with atrial fibrillation (AF), and warfarin therapy at discharge is a class I–indicated drug in patients with ischemic stroke with persistent or paroxysmal AF without contraindications. The aim was to de...
Tallennettuna:
| Päätekijät: | , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2008
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3086549/ https://ncbi.nlm.nih.gov/pubmed/19121441 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2008.08.062 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|